More and more people are suffering from gastrointestinal diseases. To better understand these conditions and provide solutions for patients, scientists are working on organoids, small three-dimensional biological structures capable....
Nirsevimab is an antibody targeting the respiratory syncytial virus (RSV). Available in France since September 2023, it is indicated in neonates and infants for the prevention of bronchiolitis caused....